243 related articles for article (PubMed ID: 22249359)
1. Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.
Goeldner C; Spooren W; Wichmann J; Prinssen EP
Psychopharmacology (Berl); 2012 Jul; 222(2):203-14. PubMed ID: 22249359
[TBL] [Abstract][Full Text] [Related]
2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
3. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.
Jenck F; Wichmann J; Dautzenberg FM; Moreau JL; Ouagazzal AM; Martin JR; Lundstrom K; Cesura AM; Poli SM; Roever S; Kolczewski S; Adam G; Kilpatrick G
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4938-43. PubMed ID: 10758169
[TBL] [Abstract][Full Text] [Related]
4. The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys.
Podlesnik CA; Ko MC; Winger G; Wichmann J; Prinssen EP; Woods JH
Psychopharmacology (Berl); 2011 Jan; 213(1):53-60. PubMed ID: 20852848
[TBL] [Abstract][Full Text] [Related]
5. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
Asth L; Ruzza C; Malfacini D; Medeiros I; Guerrini R; Zaveri NT; Gavioli EC; Calo' G
Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504
[TBL] [Abstract][Full Text] [Related]
6. The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats.
Le Pen G; Wichmann J; Moreau JL; Jenck F
Neuroreport; 2002 Mar; 13(4):451-4. PubMed ID: 11930159
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the NOP receptor signaling affects resilience to acute stress.
Holanda VAD; Pacifico S; Azevedo Neto J; Finetti L; Lobão-Soares B; Calo G; Gavioli EC; Ruzza C
J Psychopharmacol; 2019 Dec; 33(12):1540-1549. PubMed ID: 31337258
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
[TBL] [Abstract][Full Text] [Related]
9. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
Rizzi D; Bigoni R; Rizzi A; Jenck F; Wichmann J; Guerrini R; Regoli D; Calo G
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):551-5. PubMed ID: 11383716
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent.
Hirao A; Imai A; Sugie Y; Yamada Y; Hayashi S; Toide K
J Pharmacol Sci; 2008 Mar; 106(3):361-8. PubMed ID: 18319566
[TBL] [Abstract][Full Text] [Related]
11. The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510).
Varty GB; Lu SX; Morgan CA; Cohen-Williams ME; Hodgson RA; Smith-Torhan A; Zhang H; Fawzi AB; Graziano MP; Ho GD; Matasi J; Tulshian D; Coffin VL; Carey GJ
J Pharmacol Exp Ther; 2008 Aug; 326(2):672-82. PubMed ID: 18492950
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species.
Varty GB; Hyde LA; Hodgson RA; Lu SX; McCool MF; Kazdoba TM; Del Vecchio RA; Guthrie DH; Pond AJ; Grzelak ME; Xu X; Korfmacher WA; Tulshian D; Parker EM; Higgins GA
Psychopharmacology (Berl); 2005 Oct; 182(1):132-43. PubMed ID: 16025321
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.
Saccone PA; Zelenock KA; Lindsey AM; Sulima A; Rice KC; Prinssen EP; Wichmann J; Woods JH
J Pharmacol Exp Ther; 2016 Apr; 357(1):17-23. PubMed ID: 26801398
[TBL] [Abstract][Full Text] [Related]
14. Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.
Silva AI; Holanda VAD; Azevedo Neto JG; Silva Junior ED; Soares-Rachetti VP; Calo G; Ruzza C; Gavioli EC
Psychopharmacology (Berl); 2020 Jun; 237(6):1633-1642. PubMed ID: 32095915
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the nociceptin/orphanin FQ receptor on ethanol-mediated motivational effects in infant and adolescent rats.
Miranda-Morales RS; Pautassi RM
Behav Brain Res; 2016 Feb; 298(Pt A):88-96. PubMed ID: 25907741
[TBL] [Abstract][Full Text] [Related]
16. Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198).
Chang SD; Brieaddy LE; Harvey JD; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA; Decker AM; McElhinny CJ; Zhong D; Peterson EE; Navarro HA; Bruchas MR; Carroll FI
ACS Chem Neurosci; 2015 Dec; 6(12):1956-64. PubMed ID: 26367173
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of a novel nociceptin/orphanin FQ receptor agonist, 2-(3,5-dimethylpiperazin-1-yl)-1-[1-(1-methylcyclooctyl)piperidin-4-yl]-1H-benzimidazole, with anxiolytic potential.
Hirao A; Imai A; Sugie Y; Tamura T; Shimokawa H; Toide K
Eur J Pharmacol; 2008 Jan; 579(1-3):189-95. PubMed ID: 18001707
[TBL] [Abstract][Full Text] [Related]
18. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory.
Higgins GA; Kew JN; Richards JG; Takeshima H; Jenck F; Adam G; Wichmann J; Kemp JA; Grottick AJ
Eur J Neurosci; 2002 Mar; 15(5):911-22. PubMed ID: 11906533
[TBL] [Abstract][Full Text] [Related]
19. Functional heterogeneity of nociceptin/orphanin FQ receptors revealed by (+)-5a Compound and Ro 64-6198 in rat periaqueductal grey slices.
Liao YY; Teng SF; Lin LC; Kolczewski S; Prinssen EP; Lee LJ; Ho IK; Chiou LC
Int J Neuropsychopharmacol; 2011 Aug; 14(7):977-89. PubMed ID: 21029514
[TBL] [Abstract][Full Text] [Related]
20. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine.
Reiss D; Wichmann J; Tekeshima H; Kieffer BL; Ouagazzal AM
Eur J Pharmacol; 2008 Jan; 579(1-3):141-8. PubMed ID: 18031727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
